It is now well established that the clade of simian immunodeficiency viruses (SIVs) infecting west central African chimpanzees (Pan troglodytes troglodytes) and western gorillas (Gorilla gorilla gorilla) comprises the progenitors of human immunodeficiency virus type 1 (HIV-1). In this study, we have greatly expanded our previous molecular epidemiological survey of SIVcpz in wild chimpanzees in Cameroon. The new results confirm a wide but uneven distribution of SIVcpzPtt in P. t. troglodytes throughout southern Cameroon and indicate the absence of SIVcpz infection in Pan troglodytes vellerosus. Analyzing 725 fecal samples from 15 field sites, we obtained partial nucleotide sequences from 16 new SIVcpzPtt strains and determined full-length sequences for two of these. Phylogenetic analyses of these new viruses confirmed the previously reported phylogeographic clustering of SIVcpzPtt lineages, with viruses related to the ancestors of HIV-1 groups M and N circulating exclusively in southeastern and south central P. t. troglodytes communities, respectively. Importantly, the SIVcpzPtt strains from the southeastern corner of Cameroon represent a relatively isolated clade indicating a defined geographic origin of the chimpanzee precursor of HIV-1 group M. Since contacts between humans and apes continue, the possibility of ongoing transmissions of SIV from chimpanzees (or gorillas) to humans has to be considered. In this context, our finding of distinct SIVcpzPtt envelope V3 sequence clades suggests that these peptides may be useful for the serological differentiation of SIVcpzPtt and HIV-1 infections, and thus the diagnosis of new cross-species transmissions if they occurred.
Introduction
Numerous African primates are infected with simian immunodeficiency viruses (SIVs), and it is now well established that SIVs infecting chimpanzees (Pan troglodytes troglodytes) and western gorillas (Gorilla gorilla gorilla) in west central individuals (Ayouba et al., 2001; Hemelaar et al., 2006; McCutchan, 2006; Peeters et al., 1997; Vergne et al., 2003; Yamaguchi et al., 2006) .
Chimpanzees (Pan troglodytes) are classified into four subspecies but only the two subspecies from central Africa, P. t. troglodytes and Pan troglodytes schweinfurthii are infected by SIVcpz. Moreover, their viruses form divergent subspeciesspecific phylogenetic lineages, SIVcpzPtt and SIVcpzPts, respectively (Groves, 2001; Sharp et al., 2005) . All HIV-1 strains fall within the SIVcpzPtt lineage from west central Africa and no human counterpart has yet been identified for SIVcpzPts in chimpanzees from east central Africa (Santiago et al., 2003a,b; Sharp et al., 2005; Worobey et al., 2004) . Using non-invasive strategies to detect antibodies and viral RNA in ape fecal samples, we recently traced the natural reservoirs of HIV-1 groups M and N to distinct chimpanzee populations in southern Cameroon . In these communities, prevalence rates ranged from 0% to 35% and the new SIVcpzPtt viruses exhibited a significant phylogeographic clustering, suggesting that major rivers or long distances were responsible for the uneven distribution of SIVcpz strains. Although, Cameroon is also home to the Pan troglodytes vellerosus chimpanzee subspecies, which inhabits the forests north of the Sanaga River, the boundary with the range of P. t. troglodytes, no case of SIVcpz infection has thus far been identified in this subspecies, but only a few have been sampled Nerrienet et al., 2005) .
Extension of our survey in Cameroon to a second great ape species, western gorillas (Gorilla gorilla), showed that these apes are also endemically infected with a simian immunodeficiency virus, designated SIVgor . Surprisingly, the phylogenetic relationships among HIV-1, SIVcpz and SIVgor indicate that the gorilla viruses form a monophyletic lineage within the SIVcpzPtt radiation, which is much more closely related to HIV-1 group O than to any other SIV.
Although not yet detected in chimpanzees, the SIVgor virus seemed to have a P. t. troglodytes origin, and it remains to be determined whether chimpanzees transmitted HIV-1 group O-like viruses to gorillas and humans independently, or first to gorillas which then transmitted the virus to humans.
In order to confirm and extend our previous findings and to study in more detail the genetic diversity of SIVcpz strains in wild chimpanzee populations, we conducted a comprehensive follow-up study to obtain more SIVcpzPtt isolates from the same as well as from different geographic regions in Cameroon. We also characterized two new full-length genomes and analyzed V3 envelope sequences from additional SIVcpzPtt strains. The latter provides new V3 peptides as potential diagnostic tools to discriminate between SIVcpzPtt and HIV-1 infections.
Results

SIV infection of wild chimpanzees in Southern Cameroon
Fecal samples (n = 725) were collected from wild-living (non-habituated) apes at 15 forest sites, primarily located in the southern part of Cameroon (Fig. 1) . Collection sites, numbers of collected samples, species and subspecies determinations, and test results of SIVcpz antibody detection are summarized in Fig. 1 . Location of wild chimpanzee study sites in southern Cameroon. Circles indicate sampling sites from the current study (n = 15). Circles with grey shading indicate field sites that were also studied previously . WE, MT and DG are sites included only in the last study . MF, TK, MP and WE are located in the range of P.t.vellerosus, while all other sites are located in the range of P.t. troglodytes. Table 1 . Of the 725 fecal samples, 378 were of chimpanzee origin based on mtDNA analysis, with 323 from P. t. troglodytes, collected south of the Sanaga River and 55 from P. t. vellerosus, all collected north of the river. The remaining specimens were either from gorillas (G. gorilla, n = 213) and have been described in our previous study , or from other primate species (n = 75) such as baboons, agile monkeys or different Cercopithecus species. For 59 samples, the DNA was degraded and the exact species of origin could not be determined. With the exception of BB (where only gorilla samples were collected), chimpanzee samples were obtained from all other sites.
All 378 chimpanzee samples were tested for the presence of SIVcpz antibodies with the INNO-LIA HIV I/II Score Confirmation Assay. We identified a total of 40 new SIVcpz antibody-positive samples, collected at 5 of the 11 sites located within the range of P. t. troglodytes apes (Table 1) . These 40 specimens were also subjected to the enhanced chemiluminescent Western blot analysis and a similar reactivity profile was observed (Figs. 2a and b) . All samples reacted strongly with the HIV-1 p24 core antigen, and some also did with p17. Samples from the LB and MB collection sites in the south east also exhibited strong cross-reactivity with HIV-1 envelope antigens; gp41 on INNO-LIA strips and gp41, gp120, gp160 on Western blot strips. The env cross-reactivity was weaker or absent for samples collected in the south central region (DP, SL, and BM). As observed previously, all Western blot profiles of chimpanzee samples from the southeastern corner of Cameroon were indistinguishable from the HIV-1-positive human plasma control.
In our previous study, samples were collected at 10 forest sites (WE, MT, DG, CP, DP, BQ, EK, BB, MB, and LB) and in 5 of them (MT, DP, EK, MB, and LB) SIVcpzPtt infection was observed with prevalence rates ranging from 4% to 35% . For this survey, we obtained new chimpanzee samples from 6 of these 10 sites (CP, BQ, EK, DP, LB, and MB). In addition, we extended the sampling area to 5 new sites (MG, KG, SL, BM and NK) in the P. t. troglodytes range and 3 new sites (TK, MF, and MP) in the P. t. vellerosus range. Like the previously reported 23 P. t. vellerosus samples , none of the additional 55 samples collected north of the Sanaga River exhibited SIVcpz antibody reactivity, suggesting that this subspecies is not infected with SIVcpz.
We estimated the number of individuals that were sampled by taking into consideration the extent of sample degradation (0.169) and oversampling (on average, each chimpanzee was sampled 1.716 times) . From this, we calculated the prevalence of SIVcpz infection at the DP, SL, BM, LB, and MB sites. As observed before , the highest prevalence rates were seen in the southeast, 33.3% for MB and 34.5% for LB. In addition, moderate prevalence rates were observed at the other sites, 11.7% for DP, 5.4% for BM, and 4.7% for SL. In contrast to our previous study, no infected chimpanzees were found in EK, although we did identify infected chimpanzees at a new location, BM, within the Dja Reserve just below the Dja River and approximately 35 km west of EK. Furthermore, we identified positive samples at SL, located at the northern periphery of the Dja Reserve, just north of the Dja River, approximately 40 km west of DP. No evidence for SIVcpz infection was found in NK, similar to what was previously observed for BB, with both sites located west of the Boumba River. Finally, no positive samples were identified at KG and MG which were located in close proximity of DG and MT, respectively ( Fig. 1) , two sites where SIVcpz prevalence was low or absent in the previous study.
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Genetic diversity of SIVcpzPtt isolates from wild chimpanzee populations in partial pol and env regions RNA was extracted and subjected to RT-PCR amplification using consensus env (gp41 and a fragment spanning the V2-V5 region) and pol primers. SIVcpz sequences were amplified for one or more genomic regions from 16 chimpanzees (Table 2) , while despite strong antibody reactivity, one sample (MB773) was repeatedly virion RNA negative. SIVcpz sequences were obtained from all sites where antibody-positive chimpanzees were identified.
To compare the evolutionary relationships of the 16 new SIVcpzPtt viruses to each other and to previously characterized SIVcpz, SIVgor and HIV-1 strains, phylogenies were constructed using partial Pol (296 aa) and Gp41 (126 aa) sequences (Figs. 3a and b) . The relative positions of some strains, or clades, differed between the two trees, providing further evidence of recombination during the divergence of the SIVcpzPtt lineages . However, in both trees, all SIVcpzPtt strains from MB and LB, including the 12 new strains, fell into a well-supported clade which included HIV-1 group M. In contrast, two new strains from DP clustered with strains obtained from captive chimpanzees in Cameroon (CAM3 and CAM5), rather than grouping closely with the two previously obtained strains from that same location. CAM3 is thought to have been caught south of the Dja River (Nerrienet et al., 2005) , whereas the DP site lies north of the Dja River (Fig.  1) ; the precise location of capture of CAM5 is unknown. The two other strains were both from sites (SL and BM) not previously sampled. The new strain from SL was most closely related to strains previously obtained from MT, a site 130 km to the north of SL (Fig. 3c) . The new strain from BM was most closely related to the clade composed of strains from EK and HIV-1 group N. Although we were not able to amplify pol sequences from this BM1034 sample, we obtained a 500 bp region from gag, which also clustered with the EK/HIV-1 group N clade (data not shown). The BM and EK sites both lie in the Dja Reserve within the bend of the Dja River, only about 35 km apart (Fig. 3c) .
With the addition of the new strains reported here, a new aspect of the phylogeographic diversity of SIVcpzPtt is emerging. The MB and LB strains are all derived from a relatively small area spanning only about 100 km. For the partial Gp41 sequence, the average amino acid diversity among these strains is 15%, with a maximum pairwise difference of 26%. Although the DP strains do not form a monophyletic clade, their diversity is not very different from that of the MB/ LB clade (average 16%, maximum 22%). Indeed, the gp41 clade composed of strains from DP, BM and EK, as well as previously characterized strains from captive chimpanzees from Cameroon (CAM3, CAM5, CAM13), Gabon (GAB1, GAB2) and an unknown origin (US), exhibits a similar level of diversity (average 18%, maximum 25%), although these strains were collected from a much wider geographic range. Thus, while there are, as expected, numerous examples of closely related strains at the same location reflecting local transmission, the results from the DP site indicate that divergent lineages may also be found at one location. The two lineages found at the DP site represent the diversity seen across a much wider area 
Sequence analysis of two full-length SIVcpzPtt strains
To explore further the phylogeny of the SIVcpzPtt lineage, we amplified two additional full-length SIVcpzPtt strains from fecal samples collected at the MB (MB897) and DP (DP943) field Fig. 3 . Phylogenetic analysis of partial Pol (polymerase) (a) and Env (gp41, envelope transmembrane protein) (b) sequences of the newly identified SIVcpzPtt strains (asterisks). Newly and previously identified SIVcpzPtt strains sites, respectively. Using previously described RT-PCR strategies (Santiago et al., 2003a,b; Keele et al., 2006; Takehisa et al., 2007) , complete MB897 and DP943 genomes were amplified as sets of 11 and 14 partially overlapping subgenomic fragments, respectively (Fig. 4) . Direct sequence analysis of these RT-PCR products yielded positions of base mixtures as well as nucleotide differences in adjoining fragments in regions of sequence overlap but none introduced nonsense or frameshift mutations (Table 3) . Both MB897 and DP943 consensus sequences contained uninterrupted reading frames for all structural and regulatory proteins as well as intact regulatory elements.
Previous analyses showed that the phylogenetic relationships among SIVcpzPtt strains vary in different regions of the genome , presumably reflecting recombination events during the divergence of the SIVcpzPtt clade. Therefore we performed phylogenetic analyses on four regions of the proteome, namely Gag, the first part of Pol (sites 1-700), the remainder of Pol concatenated with Vif, and Env (Fig. 5c) . Consistent with the analyses based on partial Pol and Env sequences, in all four trees MB897 formed a clade with the two other strains from the same geographic region (MB66 and LB7) and with HIV-1 group M, while DP943 formed a clade with three strains whose precise geographic origins are unknown (CAM3, CAM5 and US). However, within both clades, there were significant differences in branching order among the four trees. For example, MP987 clustered with MB66 in two trees (Pol1 and Env) but with LB7 in a third (Pol2), in each case with high probabilities. Similarly, DP943 clustered with CAM3 in two trees (Gag and Pol1), but outside a clade composed of CAM3 and CAM5 in the other two trees; these results were supported by high probability values in three of the four trees. These well-supported differences in branching order are evidence of comparatively recent recombination events during the divergence of viruses within these clades, and thus imply instances of dual infection.
There were also differences in branching order at deeper points within the SIVcpzPtt clade (Fig. 5) . For example, the clade including EK505 and HIV-1 group N grouped with the MB/LB/HIV-1 cluster in Gag and Pol1, but with another cluster (DP943/CAM3/CAM5/US) in Pol2 and Env, while the relative positions of MT145, GAB2 and the cluster of GAB1/CAM13 moved among all four trees. These results point to a number of recombination events during the earlier divergence of SIVcpzPtt strains.
Genetic diversity among gp120 V3-loop sequences from different SIVcpz lineages
The V3 loop of the HIV-1 gp120 glycoprotein plays an important role in coreceptor binding of the virus, determining which coreceptor, CXCR4 or CCR5, is used for entry. Synthetic peptides derived from consensus V3-loop sequences of HIV-1 M, N and O can be used in ELISA assays to discriminate the different HIV-1 group infections (Ayouba et al., , 2001 Mauclere et al., 1997; Simon et al., 2001; Vergne et al., 2003; Yamaguchi et al., 2004 Yamaguchi et al., , 2006 . The V3 loop of HIV-1 typically consists of 35 amino acids, but varies in length (range 31-39) and exhibits extensive sequence diversity, presumably in response to immune pressures. In contrast, V3 loop sequence diversity has been found to be relatively low among previously characterized SIVcpz sequences (Vanden Haesevelde et al., 1996; Hahn et al., 2000; Bibollet-Ruche et al., 2004b) . In this study, we amplified the V2-V5 region for 10 new SIVcpz strains, extending the number of available SIVcpz V3 loop sequences to 27, with 23 derived from SIVcpzPtt and 4 from SIVcpzPts. Phenetic of these new sequences, as well as others reported in the past (Bibollet-Ruche et al., 2004b) , reveals more diversity among SIVcpz V3 loop sequences than previously found (Fig. 6) . With the exception of SIVcpzPttGAB2, which has an unusually divergent V3 loop, the SIVcpz sequences fall into two distinct phenetic clusters, one exclusively composed of SIVcpzPtt strains from LB and MB, and the other containing all other SIVcpz strains, including SIVcpzPts as well as HIV-1 group N sequences. These SIVcpz V3 sequences differ significantly from those of HIV-1 group M and O, and may thus represent distinct V3 serotypes. Among the SIVcpzPtt variants most closely related to HIV-1 group M, the crown of the V3 loop is characterized by the GPGQ motif, which is the same in the human viruses. Interestingly, the second Gly found in the GPG motif of one of these SIVcpz strains (MB66) was replaced by a Ser; the biological significance of this change is unclear. Most other SIVcpz strains, including those from P. t. schweinfurthii, encode GPGM at the crown, while the HIV-1 group N strains and two SIVcpzPtt strains (MT145 and DP935) encode GPAM.
Discussion
Our previous molecular epidemiological studies of wildliving apes in Cameroon allowed us to trace the origin of HIV-1 groups M and N to geographically isolated chimpanzee populations in southern Cameroon . We also identified for the first time SIV infection in wild gorillas and showed that this new lineage clustered within the SIVcpz radiation, as a sister clade to HIV-1 group O . In order to corroborate and extend these findings and to study in more detail the genetic diversity of SIVcpz, we conducted a more extensive survey of wild chimpanzee populations including previous and new field sites. The results from this new study confirm a wide but uneven distribution, as well as significant phylogeographic clustering, of SIVcpzPtt. We confirmed the high prevalence (30%) of SIVcpz infection in southeastern Cameroon and the absence or low to moderate prevalence (4% to 11%) in chimpanzee communities from the south-central area. Finally, there is no evidence for SIVcpz infection in P. t. vellerosus.
Thus, a total of 824 chimpanzee samples have now been studied from wild chimpanzees in Cameroon, 746 from P. t. troglodytes and 78 from P. t. vellerosus, yielding a total of 31 new SIVcpzPtt strains. All of these newly identified SIVcpzPtt strains were found to fall within the radiation of SIVcpz from P. t. troglodytes apes, confirming that chimpanzees from east and west central Africa harbor subspecies-specific SIVcpz lineages.
Within Cameroon, chimpanzee populations that are separated by major geographical barriers also harbor distinct SIVcpzPtt lineages. All SIVcpzPtt strains from the MB and LB sites formed a single well-supported clade that included HIV-1 group M, and this clade was exclusively found in southeastern Cameroon. Similarly, samples from the EK and BM sites in the Dja Reserve, just south of the Dja River, were much more closely related to HIV-1 group N than were any other identified SIVcpz strains. While strains from neighbouring chimpanzee communities collected over a small area often clustered closely together in the phylogenies, it is also important to note that certain communities harbor rather divergent SIVcpzPtt lineages. The most striking examples were LB714/ 715 and LB730, which were collected at a distance of 1 km from each other within the LB site, and DP25/DP206 and DP942/943 from DP, which were collected at a single field site. Moreover, the genetic diversity among SIVcpzPtt strains from a relatively small region within the south east was comparable to that observed among all other SIVcpzPtt strains, collected from sites across south-central Cameroon (DP, SL and MT), as well as from captive chimpanzees from the same area (CAM3, CAM5 and CAM13) and from Gabon (GAB1 and GAB2) (Corbet et al., 2000; Nerrienet et al., 2005; Peeters et al., 1989) .
Our studies in Cameroon suggest that rivers may play a major role in the phylogeographic clustering of SIVcpz. For example, the SIVcpzPtt strains most closely related to HIV-1 group N are found only in the north of the Dja Reserve, whereas just across the Dja River divergent lineages are found. Rivers could also explain the absence of SIVcpz infection in some areas. For example, the highest SIVcpzPtt prevalences were observed at the MB and LB sites in south east Cameroon, while Fig. 1 . b Dashes (-) indicate nucleotide differences between adjoining fragments in regions of sequence overlap; slashes (/) indicate positions of base mixtures; the latter are also highlighted by asterisks on the corresponding amplicon. c p6, p17 and p24 Gag, viral core proteins; TF, Transframe peptide resulting from processing of Pr160 Gag-Pol polyprotein precursor; PR, protease; RT, reverse transcriptase; Env, envelope glycoprotein. no sign of infection was detected at the BB and NK sites, separated from MB and LB by the Boumba River. Long distances may also play a role, although some viral lineages have clearly been able to spread over a wide range. Overall, and not unexpectedly, the genetic diversity among SIVcpzPtt strains is heavily influenced by the geographic origin of their hosts.
We recently identified SIV in gorillas in Cameroon . These viruses (SIVgor) cluster within the SIVcpzPtt lineage and are most closely related to HIV-1 group O. The phylogenetic position of SIVgor implies that P. t. troglodytes chimpanzees were the source of SIVgor. While we have now screened a substantial number of new samples from chimpanzees in Cameroon, including some from sites in areas which overlap with the range of the SIV-positive gorillas, we have not identified an SIVcpzPtt strain which is closely related to SIVgor or HIV-1 group O. It is possible that, subsequent to transmission to gorillas, this lineage of SIVcpzPtt has become extinct or had its origin outside Cameroon.
Two full-length genome sequences were characterized to verify the phylogenetic relationships among the different SIVcpzPtt lineages. Analysis of these sequences confirmed previously reported ancient recombination events, for example involving the ancestors of the EK strains (and hence HIV-1 group N), as well as the GAB2, MT145 and GAB1/CAM13 strains Sharp et al., 2005) . These analyses also revealed evidence for more recent recombination events among the strains in southeastern Cameroon (at MB and LB). Thus, co-infection of individual chimpanzees by (at least) two strains of SIVcpz has occurred on multiple occasions.
Although highly endangered, gorillas and chimpanzees continue to be hunted, especially in west central Africa, and remain a potential source of human infection (Matthews and Matthews, 2004) . SIVs from chimpanzees (and perhaps gorillas) are now known to have crossed the species barrier to humans on at least three occasions Sharp et al., 2005) . In addition, in West Africa there have been at least 8 cross-species transmissions of SIV from sooty mangabeys leading to distinct groups of HIV-2 (Damond et al., 2004; Santiago et al., 2005) . Thus it would be not surprising if additional cases of SIVcpz or SIVgor cross-species transmissions had occurred, especially in geographic regions where these viruses are most prevalent and where hunting pressure is high. Since SIVcpz/SIVgor infections are unlikely to be differentiated by commercial HIV-1 antibody screening assays, such transmissions may have gone unrecognized. As shown in our serological testing, some SIVcpzPtt variants elicit antibody responses that are indistinguishable from those observed in HIV-1 group M infections (see Western blot profiles of SIVcpz infections from the MB and LB sites in Fig.  2) , or from the HIV indeterminate Western blot profiles which are often observed for HIV-1 group O infections (Gurtler et al., 1994; De Leys et al., 1990; Loussert-Ajaka et al., 1994) . It is thus likely that some HIV-1 seropositive and/or seroindeterminant individuals in west central Africa are infected with the descendants of still other SIVcpz and/or SIVgor strains. Although only a fraction of human antibody-positive samples from west central Africa have been molecularly characterized, such studies have already allowed the identification and characterization of HIV-1 groups O and N in Cameroon (Gurtler et al., 1994; De Leys et al., 1990; Simon et al., 1998) . V3 peptide ELISAs have been shown to reliably identify the majority of HIV-1 group M, N and O as well as dual M/O infections (Ayouba et al., , 2001 Mauclere et al., 1997; Simon et al., 2001; Vergne et al., 2003; Yamaguchi et al., 2004 Yamaguchi et al., , 2006 . However, 10% of HIV-1-positive sera are untypeable (Vergne et al., 2003) ; while this is most probably related to the high specificity and the insufficient sensitivity of the assays, some of these samples may represent infections with other HIV-1 variants resulting from additional SIVcpz or SIVgor cross-species transmissions. It should be emphasized that HIV-1 group N was initially identified because the serum was non-reactive with HIV-1 M and O peptides, but recognized a peptide derived from SIVcpz . Subsequent genetic characterization of HIV-1 group N confirmed its close genetic relationship with SIVcpzPtt in the envelope gene (Corbet et al., 2000; Roques et al., 2004; Simon et al., 1998) . We identified a substantial number of new SIVcpzPtt V3 loop sequences, which fall into distinct phenetic clusters and differ from those of HIV-1 groups M and O by 44% to 69%, and likely represent distinct V3 serotypes. This degree of V3 loop diversity may allow the serological distinction of these SIVcpzPtt lineages and identify possible new SIVcpz or SIVgor cross-species transmissions. If additional transmissions have indeed occurred, it will be important to study to what extent these new zoonoses have spread within the human population. Such events would have important public health implications and consequences for future AIDS treatment and vaccine development. In addition to virus, host and socio-demographic factors, high HIV-1 prevalences in certain rural areas, for example around logging concessions, could also play a role in the further spread of new transmissions, in particular by recombination between HIV-1 and SIVcpz or SIVgor (Laurent et al., 2004) .
We have already sequenced full-length genomes for a subset of the new SIVcpzPtt lineages. As a next step, it will be important to characterize these viruses on a biological level to elucidate the determinants of cross-species transmission and host adaptation. These analyses may also identify factors related to further spread of the virus; for example, it is currently unknown whether the global spread of HIV-1 group M, compared to the limited spread of HIV-1 groups N and O, reflects characteristics of the progenitors of these viral clades or simply different epidemiological opportunites that they encountered. While it seems that viral isolation from fecal material is not possible, we have recently demonstrated that infectious molecular clones of SIVcpz can be generated from fecal viral consensus sequences from wild-living chimpanzees (Takehisa et al., 2007) . This new technology will allow the study of the biological characteristics of the new SIVcpzPtt strains, and yield better insights into their pathogenic potential.
In summary, the new SIVcpzPtt strains reported in this study have corroborated and extended our previous findings regarding the origins of HIV-1 groups M and N in southeastern and south central Cameroon, respectively. We have observed a high genetic diversity, generated by both divergence and recombination, among SIVcpzPtt strains from neighbouring chimpanzees communities, and confirmed the phylogeographic clustering of these viruses. Humans continue to have contact with the apes harboring these viruses, and the possibility of additional SIVcpz and/or SIVgor transmissions thus has to be considered.
Materials and methods
Sample collection and study sites
Fecal samples (n = 725) were collected from wild-living (non-habituated) apes at 15 forest sites, mainly located in the southern part of Cameroon (Fig. 1) . Twelve field sites were in the range of the P. t. troglodytes subspecies and three were north of the Sanaga River (TK, MF, and MP) in the P. t. vellerosus range ( Table 1) . Seven of the fifteen sites (EK, BM, CP, TK, BB, NK, and LB) were located in National Parks or Forest Reserves, while the remainder were in non-protected areas with considerable hunting pressure. In addition to the 7 previously sampled sites (CP, DP, BQ, EK, MB, BB, and LB) , 8 new field sites are included in this study: TK, MF, MP, MG, KG, SL, BM, and NK. Samples were collected by experienced trackers, preserved in RNAlater (a commercial preservative of nucleic acids) (Ambion, Austin, TX), stored at the base camps at room temperature (maximum 20 days), and subsequently transported to a central laboratory in Yaounde. Collection site, date, global positioning system (GPS) coordinates (when available) and species origin, as identified by visual inspection were recorded in the field.
Species and subspecies determinations
The species origin of the fecal samples was determined by mitochondrial DNA (mtDNA) analysis as described previously Van Heuverswyn et al., 2006) . Fecal DNA was extracted using the QIAamp Stool DNA Mini kit (Qiagen, Valencia, CA). Briefly, 1.5 ml of fecal RNAlater mixture was resuspended in stool lysis buffer and clarified by centrifugation. The supernatants were treated with an InhibitEx tablet (Qiagen, Valencia, CA), subjected to proteinase K digestion, and passed through a DNA binding column. Bound DNA was eluted in 50-150 μl elution buffer, and 5 μl (aliquots) were used for mitochondrial DNA amplification. First, a ∼450-to 500-bp mtDNA fragment spanning the hypervariable D loop was amplified from fecal DNA using primers L15997 (5′-CACCATTAGCACC-CAAAGCT-3′) and H16498 (5′-CCTGAAGTAGGAACCA-GATG-3′). Phylogenetic analysis of these D loop sequences allowed identification of all chimpanzee samples and their subspecies classification (P. t. troglodytes or P. t. vellerosus). Whereas the majority of gorilla samples could also be identified with this approach, some samples yielded amplification products of poor quality and were reanalyzed by amplifying a 386-bp mtDNA fragment spanning the 12SrRNA gene (using primers 12S-L1091 5′-AAAAAGCTTCAAACTGGGATTAGATACC-CCACTAT-3′ and 12S-H1478 5′-TGACTGCAGAGGGTGAC-GGGCGGTGTGT-3′). Sequence analysis of these fragments revealed that most of them were gorillas, but that some samples were not from apes and belonged to other non-human primates such as baboons or agile monkeys. Samples that scored negative in both amplification assays were considered as representing degraded material.
Microsatellite analyses
Fecal DNA was extracted from all SIVcpz antibody-positive samples for microsatellite analysis to determine the number of infected individuals as previously described . All samples were genotyped at 7 loci (D18s536, D4s243, D10s676, D2S1326, D2S1333, D4S1627 and D9S905)), with an additional locus (D9s922) amplified for a select number of samples. All PCR reactions were performed in duplicate. Individuals whose genotype appeared homozygous were amplified a minimum of seven times to exclude allelic drop out.
Detection of SIVcpz antibodies in RNAlater preserved fecal chimpanzee samples
All chimpanzee fecal samples were tested for the presence of HIV-1 cross-reactive antibodies, using the INNO-LIA HIV I/II Score Confirmation test (Innogenetics, Ghent, Belgium) as previously described . This test configuration includes HIV-1 and HIV-2 recombinant proteins and synthetic peptides, coated as discrete lines on a nylon strip. INNO-LIA-positive samples were also tested by Western blot analysis as reported previously (Calypte Biomedical; Rockville, MD) . RNAlater precipitated immunoglobulin is resolubilized by diluting fecal/RNAlater mixtures (1.5 ml) with PBS-Tween 20 (7.5 ml), followed by inactivation of the mixture for 1 h at 60°C, centrifugation (3500×g for 10 min) to clarify the solution, and then dialyzing it against PBS overnight at 4°C. The reconstituted extracts were then subjected to immunoblot analysis. Importantly, all samples containing SIVcpz antibodies scored positive in both assays.
Amplification of SIVcpz sequences from fecal RNA
Fecal RNA was extracted from all samples with HIV crossreactive antibodies and subjected to RT-PCR amplification using SIVcpz/HIV-1 consensus primers in env (gp41 ectodomain) (∼ 390 bp) and pol (∼ 340 bp or ∼ 890 bp) regions as previously described Van Heuverswyn et al., 2006) . To amplify the V3 region, additional primer sets were designed, based on the phylogenetic clustering of the SIVcpz strains (all primers are listed in Table 4 ). cDNA was synthesized using the R1 primer, followed by nested PCR using primers F1/R1 and F2/ R2. For one sample a small fragment (∼ 520 bp) in gag was amplified with the following primer set: CPZ-GAGF1 (5′-ATGGGWGCGAGRGCGTC-3′), CPZ-GAGR1 (5′-GCTT-CWGCTARNACYCTWGCCTTATG-3′), CPZ-GAGF2 (5′-ATGAAACATHTAGTWTGGGCMAG-3′) and CPZ-GAGR2 (5′-TCCCAHTCNGCDGCTTCYTCATTGAT-3′). All RT-PCR reactions were performed with the Expand Reverse Transcriptase and the Expand Long Template PCR system (Roche Diagnostics, Indianapolis, IN) according to the manufacturer's instructions. Briefly, 10 μl of fecal vRNA was used for cDNA synthesis and 20 U of RNase Inhibitor (Ambion, Austin, TX) was added to the RT-PCR mixture. The mixture was then incubated for 1 h at 42°C, followed by 5 min at 95°C to inactivate the enzyme. 10 μl of genomic DNA was used for firstround PCR amplifications and 5 μl of the first-round reaction was used for the nested PCR with second-round primers, F2/R2, by using the same thermocycling conditions. Mostly, PCR amplifications included 35 cycles of denaturation (94°C, 20 s), annealing (50°C, 30 s) and elongation (68°C, 1 min) in a Peltier Thermal Cycler (PTC-200). For some amplifications PCR Table 4 Primer sets used to amplify partial SIVcpz pol and env (gp41 and V3) sequences
Gene
Round of nested PCR conditions were slightly modified (annealing temperatures b 50°C and/or touch-down PCR strategy). Extension times varied depending on the size of the expected fragment and were typically set at 1 min/kb. The resulting amplification products were gel purified (Qiagen, Valencia, CA) and directly sequenced using an automated sequencer (3130xl Genetic Analyser, Applied Biosystems, Foster City, CA). The partial pol, gp41 and V3-loop sequences of the new SIVcpzPtt strains are available at GenBank under accession numbers: AM696210-AM696248.
Generation of full-length fecal SIVcpzPtt population sequences
SIVcpzPtt MB897 and DP943 genomes were amplified from SIVcpz antibody-positive fecal samples collected at the MB (sampled 26/04/2005) and DP (sampled 06/02/2005) field sites, Table 5 Oligonucleotide primers used to amplify full-length MB897 and DP943 viral sequences c Size of PCR amplicons. d Fragments B, C and F of MB897 and DP943 were amplified using identical primer sets. e For primer designation, also see Table 4 .
essentially as described (Santiago et al., 2003a,b; Keele et al., 2006; Takehisa et al., 2007) . Briefly, cDNA was synthesized by adding fecal vRNA (10 μl) to a RT-PCR master mix containing 1× Buffer (Invitrogen; Carlsbad, CA), 0.5 mM dNTP, 5 mM dithiothreitol, 2 pmol of primer, 20 U of RNase inhibitor (Ambion, Austin, TX), and 200 U of SuperScript RT III (Invitrogen), and by incubating the mixture for 3 h at 50°C. MB897 cDNA (6 μl) was added to a PCR mix consisting of 1× Expand Buffer II (Roche Diagnostics; Indianapolis, IN), 0.5 mM dNTP, 500 nM of PCR primers, 25 μg of bovine serum albumin and 3.75 U of Expand High-Fidelity polymerase mixture (Roche Diagnostics). Amplification conditions for both first-round and nested PCR included 35 cycles of denaturation (94°C, 0.5 min), annealing (53-60°C, 0.5 min), and extension (68°C, 1 min). DP943 amplification was conducted similarly except for using 10 μl cDNA, 0.4 mM dNTP, 400 nM primers and amplification conditions that included 55 cycles of denaturation (94°C, 0.5 min), annealing (45-52°C, 0.5 min) and extension (68°C, 1.5 min). The primers used are listed in Table 5 . Amplicons were gel-purified and sequenced directly using an ABI 3730 DNA Analyzer using Sequencer version 4.6 (Gene Codes Corporation, Ann Arbor, MI). Chromatograms were carefully examined for positions of base mixtures (Table  3 ). In addition, nucleotide differences between adjoining fragments in regions of sequence overlap were recorded (Table 3 ). The full-length MB897 (9167 bp) and DP943 (9247 bp) population sequences are available at GenBank under the accession numbers EF535994 and EF535993, respectively.
Phylogenetic analyses of SIVcpz sequences
The new SIVcpzPtt nucleotide sequences were translated and compared to various previously published sequences (see below). Protein sequences were aligned using ClustalW (Thompson et al., 1994) ; where necessary, minor manual adjustments were performed in SeaView (Galtier et al., 1996) and sites that could not be unambiguously aligned or contained a gap in any sequence were excluded from the analyses. Phylogenies were inferred by the Bayesian method (Yang and Rannala, 1997) , implemented in MrBayes version 3.1 (Ronquist and Huelsenbeck, 2003) , run for 1,000,000 generations. Parameters were examined with the Tracer program (http:// evolve.zoo.ox.ac.uk/software.html/id%3Dtracer). For the analyses of partial Pol and gp41 sequences, the numbers of amino acid sites examined were 296 and 126, respectively. Using the mixed model in MrBayes indicated that the rtREV model of amino acid change (Dimmic et al., 2002) was most appropriate; this model was used with gamma-distributed rates across sites. For the analyses of full-length sequences, four major regions of the proteome were analyzed: Gag, Pol1, Pol2, and Env. The Pol sequence was divided at the position of a recombination breakpoint previously identified in HIV-1 group N (Gao et al., 1999) . In Pol2, the carboxy-terminal region of Pol was concatenated with Vif; in the region of overlap between Pol and Vif, only the Vif sequence was included. The JTT model of amino acid change (Jones et al., 1992 ) was used, with gamma distributed rates across sites. For the analysis of the V3-loop
